+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cloning And Mutagenesis Market Size, Share & Trends Analysis Report By Product (Cloning Kits, Mutagenesis Kits), By Technology (Topo PCR Cloning, Blunt End Cloning), By End-user, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 150 Pages
  • December 2022
  • Region: Global
  • Grand View Research
  • ID: 5712521
Description Jump to:
The global cloning and mutagenesis market size is expected to reach USD 9.44 billion by 2030., expanding at a CAGR of 18.97% from 2023 to 2030. Growing focus on protein engineering for drug development and increasing demand for genetically modified products are major factors driving the market. In addition, the rising prevalence of genetic disorders and chronic diseases is increasing the demand for personalized medicine.

Cloning and mutagenesis are the basic methodologies employed in protein engineering during drug development. These techniques help researchers in the modification of protein sequences through insertion, deletion, or substitution of nucleotides to develop therapeutic proteins. In addition, cloning and mutagenesis aid in the development of more efficient and safer drugs, which can be readily available at a lower cost. For instance, currently, there are more than 200 peptide and protein drugs approved by the FDA. Hence, applications of these techniques in protein engineering are likely to fuel market growth over the forecast years.

The COVID-19 pandemic is expected to positively influence market growth. Cloning and mutagenesis techniques are used to clone the SARS-CoV-2 genome. For instance, according to an article published in Nature in May 2020, researchers have constructed a clone of the SARC-CoV-2 genome by using yeast-based method. Modifying or reconstructing genomes is essential for studying methods of infection, replication, and potential drugs and vaccines that might work against the virus. As a result, the usage of these techniques has increased due to COVID-19-related research, which is expected to fuel the market growth during the forecast period.

The growing prevalence of genetic disorders and chronic diseases is increasing the demand for personalized medicine. Cloning and mutagenesis techniques are used in studying a particular disease of an individual to aid diagnosis, develop a treatment plan, and identify the treatment effect. Moreover, increasing funding for personalized medicine is anticipated to boost the applications of cloning and mutagenesis during the study period. For instance, in February 2022, VariantyxS secured funding worth USD 41.5 million to launch novel solutions in precision oncology.

Furthermore, increasing applications of cloning and mutagenesis tools in synthetic biology are accelerating market growth. Synthetic biology is aiding in fine-tuning of already available drugs by using cloning and mutagenesis to improve their therapeutic attributes and produce minimal or no side effects for individuals. Synthetic genes created the way for oncology-focused organizations to develop personalized cancer vaccines to the specific DNA sequence of a patient’s tumor. Several such personalized cancer vaccines are in the clinical phase. There are several gene-based vaccines that are also in development to fight COVID-19, which require cloning and mutagenesis techniques to produce cost-effective and efficient vaccines. Such applications are expected to fuel the market growth during the study period.

On the other hand, high maintenance cost associated with cloning and mutagenesis tools, limited viability of qualified researchers. and the need for advanced training may limit the market growth to a certain extent. However, key players are continuously striving to develop cost-effective instruments and offering several hands-on training programs to overcome the limitations, which is likely to create growth prospects for the market.

Cloning And Mutagenesis Market Report Highlights

  • By product, the cloning kits segment held the largest share in 2022. This is attributed to the broad range of applications of these kits in biopharmaceuticals, gene therapy, and gene analysis among others
  • By technology, the TOPO PCR cloning segment held the largest share in 2022 due to the advantages associated with the technology such as ligation and restriction-free cloning and simple design of primers
  • By end-user, the biopharmaceutical and pharmaceutical companies segment held the largest share in 2022 owing to the widespread use of cloning and mutagenesis in biopharmaceuticals for drug discovery and development
  • North America dominated the global market in 2022 due to a rise in investment initiatives by the government, increasing incidence of chronic diseases such as cancer, and high demand for biotechnology techniques
  • Asia Pacific is expected to grow considerably in the future owing to the increasing R&D investment by governments, rising demand for novel therapeutics, and improving economy


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Research Methodology
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity flow approach
1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective 1:
1.11.2 Objective 2:
1.12 List of Abbreviations
Chapter 2 Market Definitions
Chapter 3 Executive Summary
3.1 Market Summary
Chapter 4 Global Cloning and Mutagenesis Market Variables, Trends, & Scope
4.1 Cloning and Mutagenesis Market Lineage Outlook
4.1.1 Parent market outlook
4.2 Penetration and Growth Prospect Mapping
4.3 Regulatory Framework
4.4 Market Driver Analysis
4.4.1 Increasing demand for personalized medicine
4.4.2 Growing focus on protein engineering
4.4.3 Rising demand for genetically modified products
4.5 Market Restraint Analysis
4.5.1 High maintanance cost associated with cloning and mutagenesis tools & instruments
4.5.2 Limited aviability of qualified researchers and need for advanced training in cloning and mutagenesis processes
4.6 Market Opportunity Analysis
4.6.1 Increasing applications of cloning and mutagenesis in synthetic biology
4.7 Porter’s Five Forces Analysis
4.8 Cloning and Mutagenesis Market: Covid-19 Impact Analysis
Chapter 5 Cloning and Mutagenesis Market - Segment Analysis, by product, 2018 - 2030 (USD Million)
5.1 Global Cloning and Mutagenesis Market: Product Movement Analysis
5.2 Cloning Kits
5.2.1 Cloning kits market estimates and forecast, 2018 - 2030 (USD Million)
5.3 Mutagenesis Kits
5.3.1 Mutagenesis kits market estimates and forecast, 2018 - 2030 (USD Million)
5.4 Others
5.4.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 6 Cloning and Mutagenesis Market - Segment Analysis, by Technology, 2018 - 2030 (USD Million)
6.1 Global Cloning and Mutagenesis Market: Technology Movement Analysis
6.2 Topo PCR Cloning
6.2.1 Topo PCR cloning market estimates and forecast, 2018 - 2030 (USD Million)
6.3 Blunt End Cloning
6.3.1Blunt end cloning market estimates and forecast, 2018 - 2030 (USD Million)
6.4 Seamless Cloning
6.4.1 Seamless cloning market estimates and forecast, 2018 - 2030 (USD Million)
6.5 Site-Directed Mutagenesis
6.5.1 Site-directed mutagenesis market estimates and forecast, 2018 - 2030 (USD Million)
6.6 Others
6.6.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 7 Cloning and Mutagenesis Market - Segment Analysis, by End-user, 2018 - 2030 (USD Million)
7.1 Cloning and Mutagenesis Market: End-user Movement Analysis
7.2 Biopharmaceutical & Pharmaceutical Companies
7.2.1 Biopharmaceutical & pharmaceutical companies market estimates and forecast, 2018 - 2030 (USD Million)
7.3 CROs & CMOs
7.3.1 CROs & CMOs market estimates and forecast, 2018 - 2030 (USD Million)
7.4. Academic & Research Institutes
7.4.1 Academic & research institutes market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 8 Cloning and Mutagenesis Market: - Segment Analysis, by Region, 2018 - 2030 (USD Million)
8.1 Cloning and Mutagenesis Market: Regional Movement Analysis
8.2 North America
8.2.1 SWOT Analysis
8.2.1.1 North America cloning and mutagenesis market, by product, 2018 - 2030 (USD Million)
8.2.1.2 North America cloning and mutagenesis market, by technology, 2018 - 2030 (USD Million)
8.2.1.3 North America cloning and mutagenesis market, by end-user, 2018 - 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 Key Country Dynamics
8.2.2.2 Target Disease Prevalence
8.2.2.3 Competitive Scenario
8.2.2.4 Regulatory Framework
8.2.2.5 Reimbursement Scenario
8.2.2.6 U.S. cloning and mutagenesis market, by product, 2018 - 2030 (USD Million)
8.2.2.7 U.S. cloning and mutagenesis market, by technology, 2018 - 2030 (USD Million)
8.2.2.8 U.S. cloning and mutagenesis market, by end-user, 2018 - 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Key Country Dynamics
8.2.3.2 Target Disease Prevalence
8.2.3.3 Competitive Scenario
8.2.3.4 Regulatory Framework
8.2.3.5 Reimbursement Scenario
8.2.3.6 Canada cloning and mutagenesis market, by product, 2018 - 2030 (USD Million)
8.2.3.7 Canada cloning and mutagenesis market, by technology, 2018 - 2030 (USD Million)
8.2.3.8 Canada cloning and mutagenesis market, by end-user, 2018 - 2030 (USD Million)
8.3 Europe
8.3.1 SWOT Analysis
8.3.1.1 Europe cloning and mutagenesis market, by product, 2018 - 2030 (USD Million)
8.3.1.2 Europe cloning and mutagenesis market, by technology, 2018 - 2030 (USD Million)
8.3.1.4 Europe cloning and mutagenesis market, by end-user, 2018 - 2030 (USD Million)
8.3.2 Germany
8.3.2.1 Key Country Dynamics
8.3.2.2 Target Disease Prevalence
8.3.2.3 Competitive Scenario
8.3.2.4 Regulatory Framework
8.3.2.5 Reimbursement Scenario
8.3.2.6 Germany cloning and mutagenesis market, by product, 2018 - 2030 (USD Million)
8.3.2.7 Germany cloning and mutagenesis market, by technology, 2018 - 2030 (USD Million)
8.3.2.8 Germany cloning and mutagenesis market, by end-user, 2018 - 2030 (USD Million)
8.3.3 U.K.
8.3.3.1 Key Country Dynamics
8.3.3.2 Target Disease Prevalence
8.3.3.3 Competitive Scenario
8.3.3.4 Regulatory Framework
8.3.3.5 Reimbursement Scenario
8.3.3.6 U.K. cloning and mutagenesis market, by product, 2018 - 2030 (USD Million)
8.3.3.7 U.K. cloning and mutagenesis market, by technology, 2018 - 2030 (USD Million)
8.3.3.8 U.K. cloning and mutagenesis market, by end-user, 2018 - 2030 (USD Million)
8.3.4 France
8.3.4.1 Key Country Dynamics
8.3.4.2 Target Disease Prevalence
8.3.4.3 Competitive Scenario
8.3.4.4 Regulatory Framework
8.3.4.5 Reimbursement Scenario
8.3.4.6 France cloning and mutagenesis market, by product, 2018 - 2030 (USD Million)
8.3.4.7 France cloning and mutagenesis market, by technology, 2018 - 2030 (USD Million)
8.3.4.8 France cloning and mutagenesis market, by end-user, 2018 - 2030 (USD Million)
8.3.5 Italy
8.3.5.1 Key Country Dynamics
8.3.5.2 Target Disease Prevalence
8.3.5.3 Competitive Scenario
8.3.5.4 Regulatory Framework
8.3.5.5 Reimbursement Scenario
8.3.5.6 Italy cloning and mutagenesis market, by product, 2018 - 2030 (USD Million)
8.3.5.7 Italy cloning and mutagenesis market, by technology, 2018 - 2030 (USD Million)
8.3.5.8 Italy cloning and mutagenesis market, by end-user, 2018 - 2030 (USD Million)
8.3.6 Spain
8.3.6.1 Key Country Dynamics
8.3.6.2 Target Disease Prevalence
8.3.6.3 Competitive Scenario
8.3.6.4 Regulatory Framework
8.3.6.5 Reimbursement Scenario
8.3.6.6 Spain cloning and mutagenesis market, by product, 2018 - 2030 (USD Million)
8.3.6.7 Spain cloning and mutagenesis market, by technology, 2018 - 2030 (USD Million)
8.3.6.8 Spain cloning and mutagenesis market, by end-user, 2018 - 2030 (USD Million)
8.3.7 Denmark
8.3.7.1 Key Country Dynamics
8.3.7.2 Target Disease Prevalence
8.3.7.3 Competitive Scenario
8.3.7.4 Regulatory Framework
8.3.7.5 Reimbursement Scenario
8.3.7.6 Denmark cloning and mutagenesis market, by product, 2018 - 2030 (USD Million)
8.3.7.7 Denmark cloning and mutagenesis market, by technology, 2018 - 2030 (USD Million)
8.3.7.8 Denmark cloning and mutagenesis market, by end-user, 2018 - 2030 (USD Million)
8.3.8 Sweden
8.3.8.1 Key Country Dynamics
8.3.8.2 Target Disease Prevalence
8.3.8.3 Competitive Scenario
8.3.8.4 Regulatory Framework
8.3.8.5 Reimbursement Scenario
8.3.8.6 Sweden cloning and mutagenesis market, by product, 2018 - 2030 (USD Million)
8.3.8.7 Sweden cloning and mutagenesis market, by technology, 2018 - 2030 (USD Million)
8.3.8.8 Sweden cloning and mutagenesis market, by end-user, 2018 - 2030 (USD Million)
8.3.9 Norway
8.3.9.1 Key Country Dynamics
8.3.9.2 Target Disease Prevalence
8.3.9.3 Competitive Scenario
8.3.9.4 Regulatory Framework
8.3.9.5 Reimbursement Scenario
8.3.9.6 Norway cloning and mutagenesis market, by product, 2018 - 2030 (USD Million)
8.3.9.7 Norway cloning and mutagenesis market, by technology, 2018 - 2030 (USD Million)
8.3.9.8 Norway cloning and mutagenesis market, by end-user, 2018 - 2030 (USD Million)
8.4 Asia Pacific
8.4.1 SWOT Analysis
8.4.1.1 Asia Pacific cloning and mutagenesis market, by product, 2018 - 2030 (USD Million)
8.4.1.2 Asia Pacific cloning and mutagenesis market, by technology, 2018 - 2030 (USD Million)
8.4.1.3 Asia Pacific cloning and mutagenesis market, by end-user, 2018 - 2030 (USD Million)
8.4.2 Japan
8.4.2.1 Key Country Dynamics
8.4.2.2 Target Disease Prevalence
8.4.2.3 Competitive Scenario
8.4.2.4 Regulatory Framework
8.4.2.5 Reimbursement Scenario
8.4.2.6 Japan cloning and mutagenesis market, by product, 2018 - 2030 (USD Million)
8.4.2.7 Japan cloning and mutagenesis market, by technology, 2018 - 2030 (USD Million)
8.4.2.8 Japan cloning and mutagenesis market, by end-user, 2018 - 2030 (USD Million)
8.4.3 China
8.4.3.1 Key Country Dynamics
8.4.3.2 Target Disease Prevalence
8.4.3.3 Competitive Scenario
8.4.3.4 Regulatory Framework
8.4.3.5 Reimbursement Scenario
8.4.3.6 China cloning and mutagenesis market, by product, 2018 - 2030 (USD Million)
8.4.3.7 China cloning and mutagenesis market, by technology, 2018 - 2030 (USD Million)
8.4.3.8 China cloning and mutagenesis market, by end-user, 2018 - 2030 (USD Million)
8.4.4 India
8.4.4.1 Key Country Dynamics
8.4.4.2 Target Disease Prevalence
8.4.4.3 Competitive Scenario
8.4.4.4 Regulatory Framework
8.4.4.5 Reimbursement Scenario
8.4.4.6 India cloning and mutagenesis market, by product, 2018 - 2030 (USD Million)
8.4.4.7 India cloning and mutagenesis market, by technology, 2018 - 2030 (USD Million)
8.4.4.8 India cloning and mutagenesis market, by end-user, 2018 - 2030 (USD Million)
8.4.5 South Korea
8.4.5.1 Key Country Dynamics
8.4.5.2 Target Disease Prevalence
8.4.5.3 Competitive Scenario
8.4.5.4 Regulatory Framework
8.4.5.5 Reimbursement Scenario
8.4.5.6 South Korea cloning and mutagenesis market, by product, 2018 - 2030 (USD Million)
8.4.5.7 South Korea cloning and mutagenesis market, by technology, 2018 - 2030 (USD Million)
8.4.5.8 South Korea cloning and mutagenesis market, by end-user, 2018 - 2030 (USD Million)
8.4.6 Australia
8.3.9.1 Key Country Dynamics
8.4.6.2 Target Disease Prevalence
8.4.6.3 Competitive Scenario
8.4.6.4 Regulatory Framework
8.4.6.5 Reimbursement Scenario
8.4.6.6 Australia cloning and mutagenesis market, by product, 2018 - 2030 (USD Million)
8.4.6.7 Australia cloning and mutagenesis market, by technology, 2018 - 2030 (USD Million)
8.4.6.8 Australia cloning and mutagenesis market, by end-user, 2018 - 2030 (USD Million)
8.4.7 Thailand
8.4.7.1 Key Country Dynamics
8.4.7.2 Target Disease Prevalence
8.4.7.3 Competitive Scenario
8.4.7.4 Regulatory Framework
8.4.7.5 Reimbursement Scenario
8.4.7.6 Thailand cloning and mutagenesis market, by product, 2018 - 2030 (USD Million)
8.4.7.7 Thailand cloning and mutagenesis market, by technology, 2018 - 2030 (USD Million)
8.4.7.8 Thailand cloning and mutagenesis market, by end-user, 2018 - 2030 (USD Million)
8.5 Latin America
8.5.1 SWOT Analysis
8.5.1.1 Latin America cloning and mutagenesis market, by product, 2018 - 2030 (USD Million)
8.5.1.2 Latin America cloning and mutagenesis market, by technology, 2018 - 2030 (USD Million)
8.5.1.3 Latin America cloning and mutagenesis market, by end-user, 2018 - 2030 (USD Million)
8.5.2 Brazil
8.5.2.1 Key Country Dynamics
8.5.2.2 Target Disease Prevalence
8.5.2.3 Competitive Scenario
8.5.2.4 Regulatory Framework
8.5.2.5 Reimbursement Scenario
8.5.2.6 Brazil cloning and mutagenesis market, by product, 2018 - 2030 (USD Million)
8.5.2.7 Brazil cloning and mutagenesis market, by technology, 2018 - 2030 (USD Million)
8.5.2.8 Brazil cloning and mutagenesis market, by end-user, 2018 - 2030 (USD Million)
8.5.3 Mexico
8.5.3.1 Key Country Dynamics
8.5.3.2 Target Disease Prevalence
8.5.3.3 Competitive Scenario
8.5.3.4 Regulatory Framework
8.5.3.5 Reimbursement Scenario
8.5.3.6 Mexico cloning and mutagenesis market, by product, 2018 - 2030 (USD Million)
8.5.3.7 Mexico cloning and mutagenesis market, by technology, 2018 - 2030 (USD Million)
8.5.3.8 Mexico cloning and mutagenesis market, by end-user, 2018 - 2030 (USD Million)
8.5.4 Argentina
8.5.4.1 Key Country Dynamics
8.5.4.2 Target Disease Prevalence
8.5.4.3 Competitive Scenario
8.5.4.4 Regulatory Framework
8.5.4.5 Reimbursement Scenario
8.5.4.6 Argentina cloning and mutagenesis market, by product, 2018 - 2030 (USD Million)
8.5.4.7 Argentina cloning and mutagenesis market, by technology, 2018 - 2030 (USD Million)
8.5.4.8 Argentina cloning and mutagenesis market, by end-user, 2018 - 2030 (USD Million)
8.6 MEA
8.6.1 SWOT Analysis
8.6.1.1 MEA cloning and mutagenesis market, by product, 2018 - 2030 (USD Million)
8.6.1.2 MEA cloning and mutagenesis market, by technology, 2018 - 2030 (USD Million)
8.6.1.3 MEA cloning and mutagenesis market, by end-user, 2018 - 2030 (USD Million)
8.6.2 South Africa
8.6.4.1 Key Country Dynamics
8.6.2.2 Target Disease Prevalence
8.6.2.3 Competitive Scenario
8.6.2.4 Regulatory Framework
8.6.2.5 Reimbursement Scenario
8.6.2.6 Argentina cloning and mutagenesis market, by product, 2018 - 2030 (USD Million)
8.6.2.7 Argentina cloning and mutagenesis market, by technology, 2018 - 2030 (USD Million)
8.6.2.8 Argentina cloning and mutagenesis market, by end-user, 2018 - 2030 (USD Million)
8.6.3 Saudi Arabia
8.6.3.1 Key Country Dynamics
8.6.3.2 Target Disease Prevalence
8.6.3.3 Competitive Scenario
8.6.3.4 Regulatory Framework
8.6.3.5 Reimbursement Scenario
8.6.3.6 Saudi Arabia cloning and mutagenesis market, by product, 2018 - 2030 (USD Million)
8.6.3.7 Saudi Arabia cloning and mutagenesis market, by technology, 2018 - 2030 (USD Million)
8.6.3.8 Saudi Arabia cloning and mutagenesis market, by end-user, 2018 - 2030 (USD Million)
8.6.4 UAE
8.6.4.1 Key Country Dynamics
8.6.4.2 Target Disease Prevalence
8.6.4.3 Competitive Scenario
8.6.4.4 Regulatory Framework
8.6.4.5 Reimbursement Scenario
8.6.4.6 UAE cloning and mutagenesis market, by product, 2018 - 2030 (USD Million)
8.6.4.7 UAE cloning and mutagenesis market, by technology, 2018 - 2030 (USD Million)
8.6.4.8 UAE cloning and mutagenesis market, by end-user, 2018 - 2030 (USD Million)
8.6.5 Kuwait
8.6.5.1 Key Country Dynamics
8.6.5.2 Target Disease Prevalence
8.6.5.3 Competitive Scenario
8.6.5.4 Regulatory Framework
8.6.5.5 Reimbursement Scenario
8.6.5.6 Kuwait cloning and mutagenesis market, by product, 2018 - 2030 (USD Million)
8.6.5.7 Kuwait cloning and mutagenesis market, by technology, 2018 - 2030 (USD Million)
8.6.5.8 Kuwait cloning and mutagenesis market, by end-user, 2018 - 2030 (USD Million)
Chapter 9 Competitive Landscape
9.1 Participant’s overview
9.1.1 Agilent Technologies, Inc.
9.1.2 Takara Bio Inc.
9.1.3 Thermo Fisher Scientific, Inc.
9.1.4 New England Biolabs
9.1.5 Merck KGaA
9.1.6 Promega Corporation
9.1.7 Bio-Rad Laboratories, Inc.
9.1.8 Danaher
9.1.9 Jena Bioscience GmbH
9.1.10 Assay Genie
9.1.11 TransGen Biotech Co., Ltd.
9.2 Financial performance
9.3 Participant categorization
9.3.1 Market leaders
9.3.1.1 Cloning & mutagenesis market share analysis, 2022
9.3.2 Strategy mapping
9.3.2.1 Expansion
9.3.2.2 Acquisition
9.3.2.3 Collaborations
9.3.2.4 Product/service launch
9.3.2.5 Partnerships
9.3.2.6 Others
List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global Cloning and Mutagenesis Market, by Product, 2018 - 2030 (USD Million)
Table 4. Global Cloning and Mutagenesis Market, by Technology, 2018 - 2030 (USD Million)
Table 5. Global Cloning and Mutagenesis Market, End-user, 2018 - 2030 (USD Million)
Table 6. Global Cloning and Mutagenesis Market, by Region, 2018 - 2030 (USD Million)
Table 7. North America Cloning and Mutagenesis Market, by Country, 2018 - 2030 (USD Million)
Table 8. North America Cloning and Mutagenesis Market, by Product, 2018 - 2030 (USD Million)
Table 9. North AmericaCloning and Mutagenesis Market, by Technology, 2018 - 2030 (USD Million)
Table 10. North America Cloning and Mutagenesis Market, End-user, 2018 - 2030 (USD Million)
Table 11. U.S. Cloning and Mutagenesis Market, by Product, 2018 - 2030 (USD Million)
Table 12. U.S. Cloning and Mutagenesis Market, by Technology, 2018 - 2030 (USD Million)
Table 13. U.S. Cloning and Mutagenesis Market, End-user, 2018 - 2030 (USD Million)
Table 14. Canada Cloning and Mutagenesis Market, by Product, 2018 - 2030 (USD Million)
Table 15. Canada Cloning and Mutagenesis Market, by Technology, 2018 - 2030 (USD Million)
Table 16. Canada Cloning and Mutagenesis Market, End-user, 2018 - 2030 (USD Million)
Table 17. Europe Cloning and Mutagenesis Market, by Country, 2018 - 2030 (USD Million)
Table 18. Europe Cloning and Mutagenesis Market, by Product, 2018 - 2030 (USD Million)
Table 19. EuropeCloning and Mutagenesis Market, by Technology, 2018 - 2030 (USD Million)
Table 20. Europe Cloning and Mutagenesis Market, End-user, 2018 - 2030 (USD Million)
Table 21. U.K. Cloning and Mutagenesis Market, by Product, 2018 - 2030 (USD Million)
Table 22. U.K. Cloning and Mutagenesis Market, by Technology, 2018 - 2030 (USD Million)
Table 23. U.K. Cloning and Mutagenesis Market, End-user, 2018 - 2030 (USD Million)
Table 24. Germany Cloning and Mutagenesis Market, by Product, 2018 - 2030 (USD Million)
Table 25. Germany Cloning and Mutagenesis Market, by Technology, 2018 - 2030 (USD Million)
Table 26. Germany Cloning and Mutagenesis Market, End-user, 2018 - 2030 (USD Million)
Table 27. France Cloning and Mutagenesis Market, by Product, 2018 - 2030 (USD Million)
Table 28. France Cloning and Mutagenesis Market, by Technology, 2018 - 2030 (USD Million)
Table 29. France Cloning and Mutagenesis Market, End-user, 2018 - 2030 (USD Million)
Table 30. Italy Cloning and Mutagenesis Market, by Product, 2018 - 2030 (USD Million)
Table 31. Italy Cloning and Mutagenesis Market, by Technology, 2018 - 2030 (USD Million)
Table 32. Italy Cloning and Mutagenesis Market, End-user, 2018 - 2030 (USD Million)
Table 33. Spain Cloning and Mutagenesis Market, by Product, 2018 - 2030 (USD Million)
Table 34. Spain Cloning and Mutagenesis Market, by Technology, 2018 - 2030 (USD Million)
Table 35. Spain Cloning and Mutagenesis Market, End-user, 2018 - 2030 (USD Million)
Table 36. Denmark Cloning and Mutagenesis Market, by Product, 2018 - 2030 (USD Million)
Table 37. Denmark Cloning and Mutagenesis Market, by Technology, 2018 - 2030 (USD Million)
Table 38. Denmark Cloning and Mutagenesis Market, End-user, 2018 - 2030 (USD Million)
Table 39. Sweden Cloning and Mutagenesis Market, by Product, 2018 - 2030 (USD Million)
Table 40. Sweden Cloning and Mutagenesis Market, by Technology, 2018 - 2030 (USD Million)
Table 41. Sweden Cloning and Mutagenesis Market, End-user, 2018 - 2030 (USD Million)
Table 42. Norway Cloning and Mutagenesis Market, by Product, 2018 - 2030 (USD Million)
Table 43. Norway Cloning and Mutagenesis Market, by Technology, 2018 - 2030 (USD Million)
Table 44. Norway Cloning and Mutagenesis Market, End-user, 2018 - 2030 (USD Million)
Table 45. Asia Pacific Cloning and Mutagenesis Market, by Country, 2018 - 2030 (USD Million)
Table 46. Asia Pacific Cloning and Mutagenesis Market, by Product, 2018 - 2030 (USD Million)
Table 47. Asia Pacific Cloning and Mutagenesis Market, by Technology, 2018 - 2030 (USD Million)
Table 48. Asia Pacific Cloning and Mutagenesis Market, End-user, 2018 - 2030 (USD Million)
Table 49. China Cloning and Mutagenesis Market, by Product, 2018 - 2030 (USD Million)
Table 50. China Cloning and Mutagenesis Market, by Technology, 2018 - 2030 (USD Million)
Table 51. China Cloning and Mutagenesis Market, End-user, 2018 - 2030 (USD Million)
Table 52. India Cloning and Mutagenesis Market, by Product, 2018 - 2030 (USD Million)
Table 53. India Cloning and Mutagenesis Market, by Technology, 2018 - 2030 (USD Million)
Table 54. India Cloning and Mutagenesis Market, End-user, 2018 - 2030 (USD Million)
Table 55. Japan Cloning and Mutagenesis Market, by Product, 2018 - 2030 (USD Million)
Table 56. Japan Cloning and Mutagenesis Market, by Technology, 2018 - 2030 (USD Million)
Table 57. Japan Cloning and Mutagenesis Market, End-user, 2018 - 2030 (USD Million)
Table 58. Thailand Cloning and Mutagenesis Market, by Product, 2018 - 2030 (USD Million)
Table 59. Thailand Cloning and Mutagenesis Market, by Technology, 2018 - 2030 (USD Million)
Table 60. Thailand Cloning and Mutagenesis Market, End-user, 2018 - 2030 (USD Million)
Table 61. Australia Cloning and Mutagenesis Market, by Product, 2018 - 2030 (USD Million)
Table 62. Australia Cloning and Mutagenesis Market, by Technology, 2018 - 2030 (USD Million)
Table 63. Australia Cloning and Mutagenesis Market, End-user, 2018 - 2030 (USD Million)
Table 64. South Korea Cloning and Mutagenesis Market, by Product, 2018 - 2030 (USD Million)
Table 65. South Korea Cloning and Mutagenesis Market, by Technology, 2018 - 2030 (USD Million)
Table 66. South Korea Cloning and Mutagenesis Market, End-user, 2018 - 2030 (USD Million)
Table 67. Latin America Cloning and Mutagenesis Market, by Country, 2018 - 2030 (USD Million)
Table 68. Latin America Cloning and Mutagenesis Market, by Product, 2018 - 2030 (USD Million)
Table 69. Latin America Cloning and Mutagenesis Market, by Technology, 2018 - 2030 (USD Million)
Table 70. Latin America Cloning and Mutagenesis Market, End-user, 2018 - 2030 (USD Million)
Table 71. Brazil Cloning and Mutagenesis Market, by Product, 2018 - 2030 (USD Million)
Table 72. Brazil Cloning and Mutagenesis Market, by Technology, 2018 - 2030 (USD Million)
Table 73. Brazil Cloning and Mutagenesis Market, End-user, 2018 - 2030 (USD Million)
Table 74. Mexico Cloning and Mutagenesis Market, by Product, 2018 - 2030 (USD Million)
Table 75. Mexico Cloning and Mutagenesis Market, by Technology, 2018 - 2030 (USD Million)
Table 76. Mexico Cloning and Mutagenesis Market, End-user, 2018 - 2030 (USD Million)
Table 77. Argentina Cloning and Mutagenesis Market, by Product, 2018 - 2030 (USD Million)
Table 78. Argentina Cloning and Mutagenesis Market, by Technology, 2018 - 2030 (USD Million)
Table 79. Argentina Cloning and Mutagenesis Market, End-user, 2018 - 2030 (USD Million)
Table 80. Middle East & Africa Cloning and Mutagenesis Market, by Country, 2018 - 2030 (USD Million)
Table 81. Middle East & Africa Cloning and Mutagenesis Market, by Product, 2018 - 2030 (USD Million)
Table 82. Middle East & Africa Cloning and Mutagenesis Market, by Technology, 2018 - 2030 (USD Million)
Table 83. Middle East & Africa Cloning and Mutagenesis Market, End-user, 2018 - 2030 (USD Million)
Table 84. South Africa Cloning and Mutagenesis Market, by Product, 2018 - 2030 (USD Million)
Table 85. South Africa Cloning and Mutagenesis Market, by Technology, 2018 - 2030 (USD Million)
Table 86. South Africa Cloning and Mutagenesis Market, End-user, 2018 - 2030 (USD Million)
Table 87. Saudi Arabia Cloning and Mutagenesis Market, by Product, 2018 - 2030 (USD Million)
Table 88. Saudi Arabia Cloning and Mutagenesis Market, by Technology, 2018 - 2030 (USD Million)
Table 89. Saudi Arabia Cloning and Mutagenesis Market, End-user, 2018 - 2030 (USD Million)
Table 90. UAE Cloning and Mutagenesis Market, by Product, 2018 - 2030 (USD Million)
Table 91. UAE Cloning and Mutagenesis Market, by Technology, 2018 - 2030 (USD Million)
Table 92. UAE Cloning and Mutagenesis Market, End-user, 2018 - 2030 (USD Million)
Table 93. Kuwait Cloning and Mutagenesis Market, by Product, 2018 - 2030 (USD Million)
Table 94. Kuwait Cloning and Mutagenesis Market, by Technology, 2018 - 2030 (USD Million)
Table 95. Kuwait Cloning and Mutagenesis Market, End-user, 2018 - 2030 (USD Million)
List of Figures
FIG. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Cloning and Mutagenesis, Market Segmentation
Fig. 8 Market Snapshot, 2022
Fig. 9 Market Trends & Outlook
Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2022
Fig. 16 Global Cloning and Mutagenesis Market: Product Movement Analysis
Fig. 17 Global Cloning and Mutagenesis Market, for Cloning Kits, 2018 - 2030 (USD Million)
Fig. 18 Global Cloning and Mutagenesis Market, for Mutagenesis Kits, 2018 - 2030 (USD Million)
Fig. 19 Global Cloning and Mutagenesis Market, for Others, 2018 - 2030 (USD Million)
Fig. 20 Global Cloning and Mutagenesis Market: Technology Movement Analysis
Fig. 21 Global Cloning and Mutagenesis Market, for Topo PCR Cloning, 2018 - 2030 (USD Million)
Fig. 22 Global Cloning and Mutagenesis Market, for Blunt End Cloning, 2018 - 2030 (USD Million)
Fig. 23 Global Cloning and Mutagenesis Market, for Seamless Cloning, 2018 - 2030 (USD Million)
Fig. 24 Global Cloning and Mutagenesis Market, for Site-Directed Mutagenesis, 2018 - 2030 (USD Million)
Fig. 25 Global Cloning and Mutagenesis Market, for Others, 2018 - 2030 (USD Million)
Fig. 26 Global Cloning and Mutagenesis Market: End-user Movement Analysis
Fig. 27 Global Cloning and Mutagenesis Market, for Biopharmaceutical & Pharmaceutical Companies, 2018 - 2030 (USD Million)
Fig. 28 Global Cloning and Mutagenesis Market, for CROs & CMOs, 2018 - 2030 (USD Million)
Fig. 29 Global Cloning and Mutagenesis Market, for Academic & Research Institutes, 2018 - 2030 (USD Million)
Fig. 30 Regional Marketplace: Key Takeaways
Fig. 31 Regional Outlook, 2022 & 2030
Fig. 32 Global Cloning and Mutagenesis Market: Regional Movement Analysis
Fig. 33 North America Cloning and Mutagenesis Market, 2018 - 2030 (USD Million)
Fig. 34 U.S. Cloning and Mutagenesis Market, 2018 - 2030 (USD Million)
Fig. 35 Canada Cloning and Mutagenesis Market, 2018 - 2030 (USD Million)
Fig. 36 Europe Cloning and Mutagenesis Market, 2018 - 2030 (USD Million)
Fig. 37 U.K. Cloning and Mutagenesis Market, 2018 - 2030 (USD Million)
Fig. 38 Germany Cloning and Mutagenesis Market, 2018 - 2030 (USD Million)
Fig. 39 France Cloning and Mutagenesis Market, 2018 - 2030 (USD Million)
Fig. 40 Italy Cloning and Mutagenesis Market, 2018 - 2030 (USD Million)
Fig. 41 Spain Cloning and Mutagenesis Market, 2018 - 2030 (USD Million)
Fig. 42 Denmark Cloning and Mutagenesis Market, 2018 - 2030 (USD Million)
Fig. 43 Sweden Cloning and Mutagenesis Market, 2018 - 2030 (USD Million)
Fig. 44 Norway Cloning and Mutagenesis Market, 2018 - 2030 (USD Million)
Fig. 45 Asia Pacific Cloning and Mutagenesis Market, 2018 - 2030 (USD Million)
Fig. 46 China Cloning and Mutagenesis Market, 2018 - 2030 (USD Million)
Fig. 47 India Cloning and Mutagenesis Market, 2018 - 2030 (USD Million)
Fig. 48 Japan Cloning and Mutagenesis Market, 2018 - 2030 (USD Million)
Fig. 49 South Korea Cloning and Mutagenesis Market, 2018 - 2030 (USD Million)
Fig. 50 Australia Cloning and Mutagenesis Market, 2018 - 2030 (USD Million)
Fig. 51 Thailand Cloning and Mutagenesis Market, 2018 - 2030 (USD Million)
Fig. 52 Latin America Cloning and Mutagenesis Market, 2018 - 2030 (USD Million)
Fig. 53 Brazil Cloning and Mutagenesis Market, 2018 - 2030 (USD Million)
Fig. 54 Mexico Cloning and Mutagenesis Market, 2018 - 2030 (USD Million)
Fig. 55 Argentina Cloning and Mutagenesis Market, 2018 - 2030 (USD Million)
Fig. 56 Middle East and Africa Cloning and Mutagenesis Market, 2018 - 2030 (USD Million)
Fig. 57 South Africa Cloning and Mutagenesis Market, 2018 - 2030 (USD Million)
Fig. 58 Saudi Arabia Cloning and Mutagenesis Market, 2018 - 2030 (USD Million)
Fig. 59 UAE Cloning and Mutagenesis Market, 2018 - 2030 (USD Million)
Fig. 60 Kuwait Cloning and Mutagenesis Market, 2018 - 2030 (USD Million)

Companies Mentioned

  • Agilent Technologies, Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific, Inc.
  • New England Biolabs
  • Merck KGaA
  • Promega Corporation
  • Bio-Rad Laboratories, Inc.
  • Danaher
  • Jena Bioscience GmbH
  • Assay Genie
  • TransGen Biotech Co., Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedDecember 2022
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 2.8 Billion
Forecasted Market Value ( USD ) by 2030 $ 9.44 Billion
Compound Annual Growth Rate18.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Global Pharmacogenomics Market by Offering (Instrument, Consumables, Software), Technology (PCR, Sequencing, Microarray), Application (Oncology, Mental Health, Cardiology, Neurology, Infectious Disease), End User (Hospitals, Academic) - Forecast to 2031 - Product Image

Global Pharmacogenomics Market by Offering (Instrument, Consumables, Software), Technology (PCR, Sequencing, Microarray), Application (Oncology, Mental Health, Cardiology, Neurology, Infectious Disease), End User (Hospitals, Academic) - Forecast to 2031

  • Report
  • 210 Pages
  • Global
From
Global Genomics Market by Technology (Sequencing, Microarray, PCR, Nucleic Acid Extraction), Application (Drug Discovery, Diagnostic, Research), End User (Pharmaceutical, Hospital, Academic), Offering (Instrument, Consumables, Software) - Forecast to 2031 - Product Image

Global Genomics Market by Technology (Sequencing, Microarray, PCR, Nucleic Acid Extraction), Application (Drug Discovery, Diagnostic, Research), End User (Pharmaceutical, Hospital, Academic), Offering (Instrument, Consumables, Software) - Forecast to 2031

  • Report
  • 320 Pages
  • Global
From
Genotyping Market Size, Share & Trends Analysis Report By Product, By Technology (PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Genotyping Market Size, Share & Trends Analysis Report By Product, By Technology (PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 180 Pages
  • Global
From
RNA Analysis Market Size, Share & Trends Analysis Report By Product (Kits & Reagents, Services, Instruments), By Technology (qPCR, Microarray, Sequencing), By Application, By End-use And Segment Forecasts, 2023-2030 - Product Image

RNA Analysis Market Size, Share & Trends Analysis Report By Product (Kits & Reagents, Services, Instruments), By Technology (qPCR, Microarray, Sequencing), By Application, By End-use And Segment Forecasts, 2023-2030

  • Report
  • 180 Pages
  • Global
From
Global Gene Synthesis Market by Product (Hardware, Services, Software), Method (Chip-Based Synthesis, PCR-Based Enzyme Synthesis, Solid-Phase Synthesis), Gene Type, Application, End-use - Forecast 2023-2030 - Product Image

Global Gene Synthesis Market by Product (Hardware, Services, Software), Method (Chip-Based Synthesis, PCR-Based Enzyme Synthesis, Solid-Phase Synthesis), Gene Type, Application, End-use - Forecast 2023-2030

  • Report
  • 183 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.